MSB Receives $4.3M Pipeline Funds from Australian Government
Filed with ASX · · 1 page · English
Earlier from Mesoblast
- MSB & NIH Agree 120 Patient Trial In End-Stage Heart Failure
- MSB Accelerates Plans for Commercial Manufacturing Operation
- Mesoblast Receives $5.05m for Stem Cell Pipeline Development
Later from Mesoblast
- Half-Year Results & Strategic Update on Product Development
- Key MPC patents granted in United States and china
- Mesoblast Corporate Overview - CEO Message to AGM
- MSB Provides Corporate Strategy For Neurologic Product
- Positive Results in Phase 2 Lumbar Spinal Fusion Trial
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast